These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9387261)

  • 21. Prognostic relevance of soluble interleukin-2 receptors in patients with ovarian tumors.
    Gebauer G; Rieger M; Jäger W; Lang N
    Anticancer Res; 1999; 19(4A):2509-11. PubMed ID: 10470184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble interleukin-2 receptor in stage I-III melanoma.
    Ottaiano A; Leonardi E; Simeone E; Ascierto PA; Scala S; Calemma R; Bryce J; Caracò C; Satriano RA; Gianfranco N; Franco R; Botti G; Castello G
    Cytokine; 2006 Feb; 33(3):150-5. PubMed ID: 16517174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Serum soluble interleukin-2 receptor in patients with pulmonary mycobacterial diseases].
    Tada A; Kawahara S; Horita N; Horiba A; Tamaoki A; Okada C; Mishima Y; Soda R; Takahashi K
    Kekkaku; 1999 Jun; 74(6):499-505. PubMed ID: 10423961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysfunction of natural killer cells in patients with transitional cell carcinoma.
    Lin CT; Yu MT; Li C; Ho YC; Shen CH; Liu DW; Chang DC; Wu SF
    Cancer Lett; 2010 May; 291(1):39-45. PubMed ID: 19931980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The value of measuring the serum level of soluble interleukin-2 receptors in lung cancer patients].
    Siemińska A
    Pol Merkur Lekarski; 2004 Feb; 16(92):188-90. PubMed ID: 15176308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The soluble interleukin-2 receptor--a marker for squamous cell carcinoma of the upper aerodigestive tract.
    Gottschlich S; Görögh T; Lippert BM; Niemann AM; Folz BJ; Werner JA
    Anticancer Res; 1997; 17(4B):2921-2. PubMed ID: 9329564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis.
    Nassonov EL; Samsonov MY; Tilz GP; Beketova TV; Semenkova EN; Baranov A; Wachter H; Fuchs D
    J Rheumatol; 1997 Apr; 24(4):666-70. PubMed ID: 9101499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The serum levels of soluble interleukin-2 receptor in patients with malignant lymphocytic proliferative disorders].
    Xu J; Wang B
    Zhonghua Xue Ye Xue Za Zhi; 1998 Feb; 19(2):82-4. PubMed ID: 10921108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
    Dejica D
    Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aspirin reduces serum anti-melanocyte antibodies and soluble interleukin-2 receptors in vitiligo patients.
    Zailaie MZ
    Saudi Med J; 2005 Jul; 26(7):1085-91. PubMed ID: 16047057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble immunological parameters and early prognosis of renal cell cancer patients.
    Kallio JP; Tammela TL; Marttinen AT; Kellokumpu-Lehtinen PL
    J Exp Clin Cancer Res; 2001 Dec; 20(4):523-8. PubMed ID: 11876546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Significance of soluble interleukin-2 receptor alpha chain in the management of patients with malignant lymphoma: a multi-center study].
    Ohno H; Ishikawa T; Kitajima H; Nomura S; Suzuki T; Konishi H; Ohno Y; Onishi R; Konaka Y; Arima N; Doi S; Nasu K; Takahashi T; Tsudo M; Fukuhara S; Uchiyama T
    Rinsho Ketsueki; 2002 Mar; 43(3):170-5. PubMed ID: 11979748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunologic indices of patients with transitional cell carcinoma of the urinary bladder].
    Bkhatta AD; Makhlin NV
    Urol Nefrol (Mosk); 1984; (2):67-70. PubMed ID: 6372193
    [No Abstract]   [Full Text] [Related]  

  • 34. Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer.
    Andrews B; Shariat SF; Kim JH; Wheeler TM; Slawin KM; Lerner SP
    J Urol; 2002 Mar; 167(3):1475-81. PubMed ID: 11832773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of serum biological markers in patients with hepatocellular carcinoma.
    Parasole R; Izzo F; Perrone F; Pignata S; Galati MG; Leonardi E; Castiglione F; Orlando R; Castello G; Esposito G; Gallo C; Daniele B
    Clin Cancer Res; 2001 Nov; 7(11):3504-9. PubMed ID: 11705869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The efficacy of recombinant interleukin 2 in local treatment of superficial bladder tumors].
    Fujioka T; Shiraishi M; Tanji S; Sato S; Koike H; Aoki H; Suzuki K; Kumagai K; Banya Y; Kubo T
    Hinyokika Kiyo; 1988 Dec; 34(12):2115-9. PubMed ID: 3266444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphocyte activation markers and von Willebrand factor antigen in Wegener's granulomatosis: potential markers for disease activity.
    D'Cruz D; Direskeneli H; Khamashta M; Hughes GR
    J Rheumatol; 1999 Jan; 26(1):103-9. PubMed ID: 9918249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum evaluation of the balance between soluble interleukin-2 and interleukin-4 receptors.
    Fujita N; Okamoto Y; Gotoh Y; Yada Y; Suzuki Y; Ando T; Togari H; Nishida M
    Cytokine; 2005 Nov; 32(3-4):143-8. PubMed ID: 16226465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The level of interleukin-2 and of soluble interleukin-2 receptor in patients with Balkan nephropathy.
    Vöö S; Drugărin D; Mărgineanu F; Koreck A; Negru S; Biriescu A
    Roum Arch Microbiol Immunol; 2002; 61(3):207-16. PubMed ID: 14752984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Levels of anti-inflammatory cytokines interleukin-2, interleukin-8, and soluble interleukin-2 receptor in blood of patients with various forms of ischemic heart disease].
    Mazurov VI; Stvolov SV; Linetskaia NE; Baldueva IA
    Ter Arkh; 2001; 73(12):14-7. PubMed ID: 11858100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.